This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and DKBMed. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Credit Designation
The Postgraduate Institute for Medicine designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
Postgraduate Instutite for Medicine is accreditecd by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Postgraduate Institue for Medicine designates tis continuing education activity for .5 contact hour(s) (0.5 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - 809-9999-17-710-H01-P)
Type of Activity
Upon successfully completing the post-test with a score of 75% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service withiin 4 weeks.
Pharmacists: Your official record of ACPE credit will be generated through the CPE Monitor System. The certificate printed after completing the evaluation for this activity is for personal tracking purposess only.
This activity is intended for primary care clinicians, pain management specialists, nurse practitioners, physician assistants, nurses, pharmacists, and any other clinicians involved in the care of patients on extended-release/long-acting (ER/LA) opioid therapy.
This activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies. Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
Michael R. Clark, MD, MPH, MBA, Consulting fees from Depomed, Collegium, Endo Advisory Boards
Yvonne D'Arcy, MS, CRNP, CNS, FAANP, Consulting Fees: Ortho McNeil, Purdue-unbranded, Practicing Clinicians-Chronic pain, Teva. Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents: Purdue, Ortho McNeil-unbranded. Royalty: Lippincott Williams & Wilkins Publishing, Springer Publishing
The Planning Committee for this activity included Nicole Fortune and Stan Pogroszewski of DKBmed, LLC. None of the aforementioned members of the Planning Committee have any significant relationships to disclose. Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. Method of Participation and Request for Credit
Please review the program in its entiretly and successfully complete the posttest with at least 70% to recieve a certificate of credit. COURSE VIEWING REQUIREMENTS
|Supported Browsers: |
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above
For video playback, install the latest version of Flash or Quicktime.
|Supported Phones & Tablets: |
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above